IL17A and cancer: Moreover, such a plastic balance between anti-inflammatory IL-17-FoxP3+Tregs and pro-inflammatory IL-17-producing Th17 cells is not only observed in cancer but also in autoimmunity and transplantation, where IL-17-producing T cells contribute to disease progression and graft rejection.